BioCentury | Feb 15, 2016
Company News

Biovica, Karolinska Institute deal

...triphosphatase ( NUDT1 ; MTH1) inhibitor cancer therapies from the institute using Biovica’s DiviTum assay. DiviTum...
BioCentury | Dec 21, 2015
Company News

Biovica, SimplicityBio deal

...The companies partnered non-exclusively to combine Biovica’s DiviTum assay with SimplicityBio’s Biomarker Optimization Software System (BOSS...
...System (BOSS) to discover, develop and commercialize improved multi-biomarker panels worldwide for advanced solid tumors. DiviTum...
Items per page:
1 - 2 of 2